[RODOS: risperidone olanzapine drug outcome studies in schizophrenia].
De Beauchamp
I
I
CHS Saint-Egrève, BP 100, 38120 Saint-Egrève.
Giraud-Baro
E
E
Gury
C
C
D014150:Antipsychotic Agents / Q000191:economics / Q000627:therapeutic use*; D001569:Benzodiazepines; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics / Q000706:statistics & numerical data; D005260:Female; D005602:France; D017048:Health Care Costs; D006801:Humans; D007391:International Cooperation; D008297:Male; D008605:Mental Health Services / Q000191:economics / Q000706:statistics & numerical data*; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use*; D012189:Retrospective Studies; D018967:Risperidone / Q000191:economics / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D018967:Risperidone; D000077152:Olanzapine